-
CHMP recommends AstraZeneca’s Qtrilmet for type 2 diabetes
pharmaceutical-technology
September 25, 2019
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the marketing authorisation of AstraZeneca’s Qtrilmet to treat type 2 diabetes in adults.
-
First oral GLP-1 treatment for type 2 diabetes approved
europeanpharmaceuticalreview
September 24, 2019
With the approval of the treatment, Rybelsus, there is a new option for treating type 2 diabetes without injections.
-
Dapagliflozin Lowers Risk for Worsening Heart Failure
drugs
September 24, 2019
For patients with heart failure and reduced ejection fraction, dapagliflozin is associated with a lower risk for worsening heart failure or death from cardiovascular causes, regardless of the presence of type 2 diabetes ...
-
Higher Fat Mass May Up Risk for Major Adverse CV Events in T2DM
drugs
September 24, 2019
In patients with type 2 diabetes, higher fat mass is associated with a higher risk for major adverse cardiovascular events ...
-
FDA Approves Rybelsus (semaglutide), the First Oral GLP-1 Analog Treatment for Adults with Type 2 Diabetes
drugs
September 23, 2019
Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved Rybelsus (semaglutide) tablets 7 mg or 14 mg for adults with type 2 diabetes that along with diet and exercise may improve blood sugar (glucose).
-
Linagliptin Noninferior for CV Risk in Early Type 2 Diabetes
drugs
September 20, 2019
According to a study published online Sept. 19 in the Journal of the American Medical Association to coincide with the annual meeting of the European Association for the Study of Diabetes ...
-
These Diets Helped Women With Diabetes Cut Heart Attack, Stroke Risk
drugs
September 20, 2019
Eating patterns similar to the Mediterranean diet and the blood pressure-lowering DASH may help older women with Type 2 diabetes ward off heart attacks, strokes and related problems, new research suggests.
-
Keeping Blood Sugar Steady Helps You Live Longer With Diabetes
drugs
September 20, 2019
Keeping your blood sugar levels stable over time may be key to living longer if you have type 2 diabetes.
-
Rates of Diabetes Higher at Lower BMIs Among Minorities
drugs
September 20, 2019
According to a study published online Sept. 19 in Diabetes Care, even at lower body weights, members of certain racial and ethnic-minority groups have a higher prevalence of diabetes or prediabetes than whites.
-
Diabetes Distress Common at Large Midwestern University
drugs
September 19, 2019
According to a study published in the September issue of the Journal of the American Osteopathic Association, in a large university population, the prevalence of diabetes distress is high ...